Pharmaceuticals

Global Somatostatin Market Insights, Forecast to 2025

  • QYR2791224
  • 129 Pages
  • October 2018
  • Pharmaceuticals
Download Sample    Get Discount   
 
This report studies the global market size of Somatostatin in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Somatostatin in these regions.

This research report categorizes the global Somatostatin market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

Somatostatin is one kind of hormone. It is widely distributed throughout the body, especially in the hypothalamus and pancreas. It also acts as an important regulator of endocrine and nervous system function by inhibiting the secretion of several other hormones such as growth hormone, insulin, and gastrin.

Somatostatin is one of the fastest growing medical Products in recent years in China. China is also the world's most rapid expansion Market. Rapid growth numbers of general hospital form a strong Market Demand of Somatostatin, especially the demand of second class and below second class hospital.

As the analogue is expanding in the market, and the price of Somatostatin not decreasing so much, Somatostatin will limited in many regions, like North America and EU. Even though the analogue and regional limited, the consumption of Somatostatin is keeping quick growth rate.

In 2017, the global Somatostatin market size was 210 million US$ and is forecast to 460 million US in 2025, growing at a CAGR of 11.4% from 2018. The objectives of this study are to define, segment, and project the size of the Somatostatin market based on company, product type, application and key regions.

The various contributors involved in the value chain of Somatostatin include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Somatostatin include

Merck (Schweiz) AG

SANOFI-AVENTIS FRANCE

Lyomark Pharma GmbH

ALFA WASSERMANN S.p.A.

Polypeptide Laboratories, Inc

SAMARTH

UBPL

HYBIO

TianTaiShan

Yangtze River

Siyao

Shuangcheng

Hainan Zhonghe

SL PHARM

Wuhan Hualong

Qingdao Guoda

Chengdu Shengnuo

Longjin

Market Size Split by Type

0.25

0.75

3

Market Size Split by Application

Application 1

Application 2

Market size split by Region

North America

United States

Canada

Mexico

Asia-Pacific

China

India

Japan

South Korea

Australia

Indonesia

Singapore

Malaysia

Philippines

Thailand

Vietnam

Europe

Germany

France

UK

Italy

Spain

Russia

Central & South America

Brazil

Rest of Central & South America

Middle East & Africa

GCC Countries

Turkey

Egypt

South Africa

The study objectives of this report are:

To study and analyze the global Somatostatin market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.

To understand the structure of Somatostatin market by identifying its various subsegments.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

Focuses on the key global Somatostatin manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

To analyze the Somatostatin with respect to individual growth trends, future prospects, and their contribution to the total market.

To project the value and volume of Somatostatin submarkets, with respect to key regions (along with their respective key countries).

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Somatostatin are as follows:

History Year: 2013-2017

Base Year: 2017

Estimated Year: 2018

Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Somatostatin market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Study Coverage

1.1 Somatostatin Product

1.2 Key Market Segments

1.3 Key Manufacturers Covered

1.4 Market by Type

1.4.1 Global Somatostatin Market Size Growth Rate by Type

1.4.2 0.25

1.4.3 0.75

1.4.4 3

1.5 Market by Application

1.5.1 Global Somatostatin Market Size Growth Rate by Application

1.5.2 Application 1

1.5.3 Application 2

1.6 Study Objectives

1.7 Years Considered

2 Executive Summary

2.1 Global Somatostatin Market Size

2.1.1 Global Somatostatin Revenue 2016-2025

2.1.2 Global Somatostatin Sales 2016-2025

2.2 Somatostatin Growth Rate by Regions

2.2.1 Global Somatostatin Sales by Regions

2.2.2 Global Somatostatin Revenue by Regions

3 Breakdown Data by Manufacturers

3.1 Somatostatin Sales by Manufacturers

3.1.1 Somatostatin Sales by Manufacturers

3.1.2 Somatostatin Sales Market Share by Manufacturers

3.1.3 Global Somatostatin Market Concentration Ratio (CR5 and HHI)

3.2 Somatostatin Revenue by Manufacturers

3.2.1 Somatostatin Revenue by Manufacturers (2016-2018)

3.2.2 Somatostatin Revenue Share by Manufacturers (2016-2018)

3.3 Somatostatin Price by Manufacturers

3.4 Somatostatin Manufacturing Base Distribution, Product Types

3.4.1 Somatostatin Manufacturers Manufacturing Base Distribution, Headquarters

3.4.2 Manufacturers Somatostatin Product Category

3.4.3 Date of International Manufacturers Enter into Somatostatin Market

3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type

4.1 Global Somatostatin Sales by Type

4.2 Global Somatostatin Revenue by Type

4.3 Somatostatin Price by Type

5 Breakdown Data by Application

5.1 Overview

5.2 Global Somatostatin Breakdown Data by Application

6 North America

6.1 North America Somatostatin by Countries

6.1.1 North America Somatostatin Sales by Countries

6.1.2 North America Somatostatin Revenue by Countries

6.1.3 United States

6.1.4 Canada

6.1.5 Mexico

6.2 North America Somatostatin by Type

6.3 North America Somatostatin by Application

6.4 North America Somatostatin by Company

7 Europe

7.1 Europe Somatostatin by Countries

7.1.1 Europe Somatostatin Sales by Countries

7.1.2 Europe Somatostatin Revenue by Countries

7.1.3 Germany

7.1.4 France

7.1.5 UK

7.1.6 Italy

7.1.7 Russia

7.2 Europe Somatostatin by Type

7.3 Europe Somatostatin by Application

7.4 Europe Somatostatin by Company

8 Asia Pacific

8.1 Asia Pacific Somatostatin by Countries

8.1.1 Asia Pacific Somatostatin Sales by Countries

8.1.2 Asia Pacific Somatostatin Revenue by Countries

8.1.3 China

8.1.4 Japan

8.1.5 Korea

8.1.6 India

8.1.7 Australia

8.1.8 Indonesia

8.1.9 Malaysia

8.1.10 Philippines

8.1.11 Thailand

8.1.12 Vietnam

8.1.13 Singapore

8.2 Asia Pacific Somatostatin by Type

8.3 Asia Pacific Somatostatin by Application

8.4 Asia Pacific Somatostatin by Company

9 Central & South America

9.1 Central & South America Somatostatin by Countries

9.1.1 Central & South America Somatostatin Sales by Countries

9.1.2 Central & South America Somatostatin Revenue by Countries

9.1.3 Brazil

9.2 Central & South America Somatostatin by Type

9.3 Central & South America Somatostatin by Application

9.4 Central & South America Somatostatin by Company

10 Middle East and Africa

10.1 Middle East and Africa Somatostatin by Countries

10.1.1 Middle East and Africa Somatostatin Sales by Countries

10.1.2 Middle East and Africa Somatostatin Revenue by Countries

10.1.3 GCC Countries

10.1.4 Turkey

10.1.5 Egypt

10.1.6 South Africa

10.2 Middle East and Africa Somatostatin by Type

10.3 Middle East and Africa Somatostatin by Application

10.4 Middle East and Africa Somatostatin by Company

11 Company Profiles

11.1 Merck (Schweiz) AG

11.1.1 Merck (Schweiz) AG Company Details

11.1.2 Company Description

11.1.3 Sales, Revenue and Gross Margin of Somatostatin

11.1.4 Somatostatin Product Description

11.1.5 Recent Development

11.2 SANOFI-AVENTIS FRANCE

11.2.1 SANOFI-AVENTIS FRANCE Company Details

11.2.2 Company Description

11.2.3 Sales, Revenue and Gross Margin of Somatostatin

11.2.4 Somatostatin Product Description

11.2.5 Recent Development

11.3 Lyomark Pharma GmbH

11.3.1 Lyomark Pharma GmbH Company Details

11.3.2 Company Description

11.3.3 Sales, Revenue and Gross Margin of Somatostatin

11.3.4 Somatostatin Product Description

11.3.5 Recent Development

11.4 ALFA WASSERMANN S.p.A.

11.4.1 ALFA WASSERMANN S.p.A. Company Details

11.4.2 Company Description

11.4.3 Sales, Revenue and Gross Margin of Somatostatin

11.4.4 Somatostatin Product Description

11.4.5 Recent Development

11.5 Polypeptide Laboratories, Inc

11.5.1 Polypeptide Laboratories, Inc Company Details

11.5.2 Company Description

11.5.3 Sales, Revenue and Gross Margin of Somatostatin

11.5.4 Somatostatin Product Description

11.5.5 Recent Development

11.6 SAMARTH

11.6.1 SAMARTH Company Details

11.6.2 Company Description

11.6.3 Sales, Revenue and Gross Margin of Somatostatin

11.6.4 Somatostatin Product Description

11.6.5 Recent Development

11.7 UBPL

11.7.1 UBPL Company Details

11.7.2 Company Description

11.7.3 Sales, Revenue and Gross Margin of Somatostatin

11.7.4 Somatostatin Product Description

11.7.5 Recent Development

11.8 HYBIO

11.8.1 HYBIO Company Details

11.8.2 Company Description

11.8.3 Sales, Revenue and Gross Margin of Somatostatin

11.8.4 Somatostatin Product Description

11.8.5 Recent Development

11.9 TianTaiShan

11.9.1 TianTaiShan Company Details

11.9.2 Company Description

11.9.3 Sales, Revenue and Gross Margin of Somatostatin

11.9.4 Somatostatin Product Description

11.9.5 Recent Development

11.10 Yangtze River

11.10.1 Yangtze River Company Details

11.10.2 Company Description

11.10.3 Sales, Revenue and Gross Margin of Somatostatin

11.10.4 Somatostatin Product Description

11.10.5 Recent Development

11.11 Siyao

11.12 Shuangcheng

11.13 Hainan Zhonghe

11.14 SL PHARM

11.15 Wuhan Hualong

11.16 Qingdao Guoda

11.17 Chengdu Shengnuo

11.18 Longjin

12 Market Opportunities, Challenges, Risks and Influences Factors Analysis

12.1 Market Opportunities and Drivers

12.2 Market Challenges

12.3 Market Risks/Restraints

12.4 Key World Economic Indicators

13 Value Chain and Sales Channels Analysis

13.1 Value Chain Analysis

13.1.1 Typical Suppliers of Key Somatostatin Raw Material

13.1.2 Somatostatin Customers

13.2 Sales Channels Analysis

13.2.1 Sales Channels Analysis

13.2.2 Distributors

14 Research Findings and Conclusion

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.1.1 Research Programs/Design

15.1.1.2 Market Size Estimation

15.1.1.3 Market Breakdown and Data Triangulation

15.1.2 Data Source

15.1.2.1 Secondary Sources

15.1.2.2 Primary Sources

15.2 Author Details

15.3 Disclaimer

List of Tables and Figures

Figure Picture of Somatostatin

Figure Global Somatostatin Production (K Pcs) and CAGR (%) Comparison by Types (Product Category) (2013-2025)

Figure Global Somatostatin Production Market Share by Types (Product Category) in 2017

Figure 0.25 Product Picture

Table Major Manufacturers of 0.25

Figure 0.75 Product Picture

Table Major Manufacturers of 0.75

Figure 3 Product Picture

Table Major Manufacturers of 3

Table Global Somatostatin Market Size Growth Rate by Application 2018-2025 (K Pcs)

Figure Application 1

Figure Application 2

Figure Somatostatin Report Years Considered

Figure Global Somatostatin Market Size 2016-2025 (Million US$)

Figure Global Somatostatin Sales 2016-2025 (K Pcs)

Table Global Somatostatin Market Size by Regions 2016-2025 (K Pcs) & (Million US$)

Table Global Somatostatin Sales by Regions 2016-2025 (K Pcs)

Table Global Somatostatin Sales Market Share by Regions 2016-2025

Figure Global Somatostatin Sales Market Share by Regions 2016-2025

Figure 2017 Global Somatostatin Sales Market Share by Regions

Table Global Somatostatin Revenue by Regions 2016-2025 (Million US$)

Table Global Somatostatin Revenue Market Share by Regions 2016-2025

Figure Global Somatostatin Revenue Market Share by Regions 2016-2025

Figure 2017 Global Somatostatin Revenue Market Share by Regions

Table Global Somatostatin Sales by Manufacturers (2016-2018) (K Pcs)

Table Global Somatostatin Sales Share by Manufacturers (2016-2018)

Figure Global Somatostatin Sales Share by Manufacturers in 2017

Table Somatostatin Revenue by Manufacturers (2016-2018) (Million US$)

Table Somatostatin Revenue Share by Manufacturers (2016-2018)

Figure Somatostatin Value Share by Manufacturers in 2017

Table Global Somatostatin Manufacturers Market Concentration Ratio (CR5 and HHI)

Table Key Manufacturers Somatostatin Price (2016-2018) (USD/Pcs)

Table Somatostatin Manufacturers Manufacturing Base Distribution and Headquarters

Table Manufacturers Somatostatin Product Category

Table Date of International Manufacturers Enter into Somatostatin Market

Table Manufacturers Mergers & Acquisitions, Expansion Plans

Table Global Somatostatin Sales by Type (2016-2025) (K Pcs)

Table Global Somatostatin Sales Share by Type (2016-2025)

Figure Global Somatostatin Sales Market Share by Type (2016-2025)

Figure Global Somatostatin Sales Market Share by Type in 2017

Table Global Somatostatin Revenue by Type (2016-2025) (Million US$)

Table Global Somatostatin Revenue Share by Type (2016-2025)

Figure Global Somatostatin Revenue Market Share by Type (2016-2025)

Figure Global Somatostatin Revenue Market Share by Type in 2017

Table Somatostatin Price by Type 2013-2018 (USD/Pcs)

Table Global Somatostatin Sales by Application (2016-2025) (K Pcs)

Table Global Somatostatin Sales Share by Application (2016-2025)

Figure Global Sales Somatostatin Market Share by Application (2016-2025)

Figure Global Sales Somatostatin Market Share by Application (2016-2025)

Figure North America Somatostatin Sales Growth Rate 2016-2025 (K Pcs)

Figure North America Somatostatin Revenue Growth Rate 2016-2025 (Million US$)

Table North America Somatostatin Sales by Countries (2016-2025) (K Pcs)

Table North America Somatostatin Sales Market Share by Countries (2016-2025)

Figure 2017 North America Somatostatin Sales Market Share by Countries

Table North America Somatostatin Revenue by Countries (2016-2025) (Million US$)

Table North America Somatostatin Revenue Market Share by Countries (2016-2025)

Figure 2017 North America Somatostatin Revenue Market Share by Countries

Figure United States Somatostatin Sales Growth Rate (2016-2025) (K Pcs)

Figure United States Somatostatin Revenue Growth Rate (2016-2025) (Million US$)

Figure Canada Somatostatin Sales Growth Rate (2016-2025) (K Pcs)

Figure Canada Somatostatin Revenue Growth Rate (2016-2025) (Million US$)

Figure Mexico Somatostatin Sales Growth Rate (2016-2025) (K Pcs)

Figure Mexico Somatostatin Revenue Growth Rate (2016-2025) (Million US$)

Table North America Somatostatin Sales by Type (2016-2025) (K Pcs)

Table North America Somatostatin Sales Market Share by Type (2016-2025)

Figure 2017 North America Somatostatin Market Share by Type

Table North America Somatostatin Sales by Application (2016-2025) (K Pcs)

Table North America Somatostatin Sales Market Share by Application (2016-2025)

Figure 2017 North America Somatostatin Market Share by Application

Table North America Somatostatin Sales by Company (2016-2018) (K Pcs)

Table North America Somatostatin Sales Market Share by Company (2016-2018)

Figure North America Somatostatin Sales Market Share by Company in 2017

Figure Europe Somatostatin Sales Growth Rate 2016-2025 (K Pcs)

Figure Europe Somatostatin Revenue Growth Rate 2016-2025 (Million US$)

Table Europe Somatostatin Sales by Countries (2016-2025) (K Pcs)

Table Europe Somatostatin Sales Market Share by Countries (2016-2025)

Figure 2017 Europe Somatostatin Sales Market Share by Countries

Table Europe Somatostatin Revenue by Countries (2016-2025) (Million US$)

Table Europe Somatostatin Revenue Market Share by Countries (2016-2025)

Figure 2017 Europe Somatostatin Revenue Market Share by Countries

Figure Germany Somatostatin Sales Growth Rate (2016-2025) (K Pcs)

Figure Germany Somatostatin Revenue Growth Rate (2016-2025) (K Pcs)

Figure France Somatostatin Sales Growth Rate (2016-2025) (K Pcs)

Figure France Somatostatin Revenue Growth Rate (2016-2025) (K Pcs)

Figure UK Somatostatin Sales Growth Rate (2016-2025) (K Pcs)

Figure UK Somatostatin Revenue Growth Rate (2016-2025) (Million US$)

Figure Italy Somatostatin Sales Growth Rate (2016-2025) (K Pcs)

Figure Italy Somatostatin Revenue Growth Rate (2016-2025) (Million US$)

Figure Russia Somatostatin Sales Growth Rate (2016-2025) (K Pcs)

Figure Russia Somatostatin Revenue Growth Rate (2016-2025) (Million US$)

Table Europe Somatostatin Sales by Type (2016-2025) (K Pcs)

Table Europe Somatostatin Sales Market Share by Type (2016-2025)

Figure 2017 Europe Somatostatin Market Share by Type

Table Europe Somatostatin Sales by Application (2016-2025) (K Pcs)

Table Europe Somatostatin Sales Market Share by Application (2016-2025)

Figure 2017 Europe Somatostatin Market Share by Application

Table Europe Somatostatin Sales by Company (2016-2018) (K Pcs)

Table Europe Somatostatin Sales Market Share by Company (2016-2018)

Figure Europe Somatostatin Sales Market Share by Company in 2017

Figure Asia Pacific Somatostatin Sales Growth Rate 2016-2025 (K Pcs)

Figure Asia Pacific Somatostatin Revenue Growth Rate 2016-2025 (Million US$)

Table Asia Pacific Somatostatin Sales by Countries (2016-2025) (K Pcs)

Table Asia Pacific Somatostatin Sales Market Share by Countries (2016-2025)

Figure 2017 Asia Pacific Somatostatin Sales Market Share by Countries

Table Asia Pacific Somatostatin Revenue by Countries (2016-2025) (Million US$)

Table Asia Pacific Somatostatin Revenue Market Share by Countries (2016-2025)

Figure 2017 Asia Pacific Somatostatin Revenue Market Share by Countries

Figure China Somatostatin Sales Growth Rate (2016-2025) (K Pcs)

Figure China Somatostatin Revenue Growth Rate (2016-2025) (Million US$)

Figure Japan Somatostatin Sales Growth Rate (2016-2025) (K Pcs)

Figure Japan Somatostatin Revenue Growth Rate (2016-2025) (Million US$)

Figure Korea Somatostatin Sales Growth Rate (2016-2025) (K Pcs)

Figure Korea Somatostatin Revenue Growth Rate (2016-2025) (Million US$)

Figure India Somatostatin Sales Growth Rate (2016-2025) (K Pcs)

Figure India Somatostatin Revenue Growth Rate (2016-2025) (Million US$)

Figure Australia Somatostatin Sales Growth Rate (2016-2025) (K Pcs)

Figure Australia Somatostatin Revenue Growth Rate (2016-2025) (Million US$)

Figure Indonesia Somatostatin Sales Growth Rate (2016-2025) (K Pcs)

Figure Indonesia Somatostatin Revenue Growth Rate (2016-2025) (Million US$)

Figure Malaysia Somatostatin Sales Growth Rate (2016-2025) (K Pcs)

Figure Malaysia Somatostatin Revenue Growth Rate (2016-2025) (Million US$)

Figure Philippines Somatostatin Sales Growth Rate (2016-2025) (K Pcs)

Figure Philippines Somatostatin Revenue Growth Rate (2016-2025) (Million US$)

Figure Thailand Somatostatin Sales Growth Rate (2016-2025) (K Pcs)

Figure Thailand Somatostatin Revenue Growth Rate (2016-2025) (Million US$)

Figure Vietnam Somatostatin Sales Growth Rate (2016-2025) (K Pcs)

Figure Vietnam Somatostatin Revenue Growth Rate (2016-2025) (Million US$)

Figure Singapore Somatostatin Sales Growth Rate (2016-2025) (K Pcs)

Figure Singapore Somatostatin Revenue Growth Rate (2016-2025) (Million US$)

Table Asia Pacific Somatostatin Sales by Type (2016-2025) (K Pcs)

Table Asia Pacific Somatostatin Sales Market Share by Type (2016-2025)

Figure 2017 Asia Pacific Somatostatin Market Share by Type

Table Asia Pacific Somatostatin Sales by Application (2016-2025) (K Pcs)

Table Asia Pacific Somatostatin Sales Market Share by Application (2016-2025)

Figure 2017 Asia Pacific Somatostatin Market Share by Application

Table Asia Pacific Somatostatin Sales by Company (2016-2018) (K Pcs)

Table Asia Pacific Somatostatin Sales Market Share by Company (2016-2018)

Figure Asia Pacific Somatostatin Sales Market Share by Company in 2017

Figure Central & South America Somatostatin Sales Growth Rate 2016-2025 (K Pcs)

Figure Central & South America Somatostatin Revenue Growth Rate 2016-2025 (Million US$)

Table Central & South America Somatostatin Sales by Countries (2016-2025) (K Pcs)

Table Central & South America Somatostatin Sales Market Share by Countries (2016-2025)

Figure 2017 Central & South America Somatostatin Sales Market Share by Countries

Table Central & South America Somatostatin Revenue by Countries (2016-2025) (Million US$)

Table Central & South America Somatostatin Revenue Market Share by Countries (2016-2025)

Figure 2017 Central & South America Somatostatin Revenue Market Share by Countries

Figure Brazil Somatostatin Sales Growth Rate (2016-2025) (K Pcs)

Figure Brazil Somatostatin Revenue Growth Rate (2016-2025) (Million US$)

Figure Argentina Somatostatin Sales Growth Rate (2016-2025) (K Pcs)

Figure Argentina Somatostatin Revenue Growth Rate (2016-2025) (Million US$)

Table Central & South America Somatostatin Sales by Type (2016-2025) (K Pcs)

Table Central & South America Somatostatin Sales Market Share by Type (2016-2025)

Figure 2017 Central & South America Somatostatin Market Share by Type

Table Central & South America Somatostatin Sales by Application (2016-2025) (K Pcs)

Table Central & South America Somatostatin Sales Market Share by Application (2016-2025)

Figure 2017 Central & South America Somatostatin Market Share by Application

Table Central & South America Somatostatin Sales by Company (2016-2018) (K Pcs)

Table Central & South America Somatostatin Sales Market Share by Company (2016-2018)

Figure Central & South America Somatostatin Sales Market Share by Company in 2017

Figure Middle East and Africa Somatostatin Sales Growth Rate 2016-2025 (K Pcs)

Figure Middle East and Africa Somatostatin Revenue Growth Rate 2016-2025 (Million US$)

Table Middle East and Africa Somatostatin Sales by Countries (2016-2025) (K Pcs)

Table Middle East and Africa Somatostatin Sales Market Share by Countries (2016-2025)

Figure 2017 Middle East and Africa Somatostatin Sales Market Share by Countries

Table Middle East and Africa Somatostatin Revenue by Countries (2016-2025) (Million US$)

Table Middle East and Africa Somatostatin Revenue Market Share by Countries (2016-2025)

Figure 2017 Middle East and Africa Somatostatin Revenue Market Share by Countries

Figure GCC Countries Somatostatin Sales Growth Rate (2016-2025) (K Pcs)

Figure GCC Countries Somatostatin Revenue Growth Rate (2016-2025) (Million US$)

Figure Turkey Somatostatin Sales Growth Rate (2016-2025) (K Pcs)

Figure Turkey Somatostatin Revenue Growth Rate (2016-2025) (Million US$)

Figure Egypt Somatostatin Sales Growth Rate (2016-2025) (K Pcs)

Figure Egypt Somatostatin Revenue Growth Rate (2016-2025) (Million US$)

Figure South Africa Somatostatin Sales Growth Rate (2016-2025) (K Pcs)

Figure South Africa Somatostatin Revenue Growth Rate (2016-2025) (Million US$)

Table Middle East and Africa Somatostatin Sales by Type (2016-2025) (K Pcs)

Table Middle East and Africa Somatostatin Sales Market Share by Type (2016-2025)

Figure 2017 Middle East and Africa Somatostatin Market Share by Type

Table Middle East and Africa Somatostatin Sales by Application (2016-2025) (K Pcs)

Table Middle East and Africa Somatostatin Sales Market Share by Application (2016-2025)

Figure 2017 Middle East and Africa Somatostatin Market Share by Application

Table Middle East and Africa Somatostatin Sales by Company (2016-2018) (K Pcs)

Table Middle East and Africa Somatostatin Sales Market Share by Company (2016-2018)

Figure Middle East and Africa Somatostatin Sales Market Share by Company in 2017

Table Merck (Schweiz) AG Company Details

Table Merck (Schweiz) AG Somatostatin Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)

Table Merck (Schweiz) AG Recent Development

Table SANOFI-AVENTIS FRANCE Company Details

Table SANOFI-AVENTIS FRANCE Somatostatin Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)

Table SANOFI-AVENTIS FRANCE Recent Development

Table Lyomark Pharma GmbH Company Details

Table Lyomark Pharma GmbH Somatostatin Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)

Table Lyomark Pharma GmbH Recent Development

Table ALFA WASSERMANN S.p.A. Company Details

Table ALFA WASSERMANN S.p.A. Somatostatin Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)

Table ALFA WASSERMANN S.p.A. Recent Development

Table Polypeptide Laboratories, Inc Company Details

Table Polypeptide Laboratories, Inc Somatostatin Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)

Table Polypeptide Laboratories, Inc Recent Development

Table SAMARTH Company Details

Table SAMARTH Somatostatin Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)

Table SAMARTH Recent Development

Table UBPL Company Details

Table UBPL Somatostatin Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)

Table UBPL Recent Development

Table HYBIO Company Details

Table HYBIO Somatostatin Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)

Table HYBIO Recent Development

Table TianTaiShan Company Details

Table TianTaiShan Somatostatin Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)

Table TianTaiShan Recent Development

Table Yangtze River Company Details

Table Yangtze River Somatostatin Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)

Table Yangtze River Recent Development

Table Siyao Company Details

Table Shuangcheng Company Details

Table Hainan Zhonghe Company Details

Table SL PHARM Company Details

Table Wuhan Hualong Company Details

Table Qingdao Guoda Company Details

Table Chengdu Shengnuo Company Details

Table Longjin Company Details

Figure GDP by Regions / Largest Economies Pie Chart in 2016

Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060

Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016

Figure Saving Rate Total, % of GDP, 2015

Table Somatostatin Value Chain

Table Typical Suppliers of Key Somatostatin Raw Material

Table Somatostatin Customers List

Table Somatostatin Sales Channels

Table Somatostatin Distributors List

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Sources

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370